Results 31 to 40 of about 14,242 (206)

First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer [PDF]

, 2013
AIM: To investigate activity, toxicity, and prognostic factors for survival of erlotinib and fixed dose-rate gemcitabine (FDR-Gem) in advanced pancreatic cancer.
Bria, E., Cognetti, F., Gamucci, T., Gelibter, A., Mansueto, G., Milella, M., Moscetti, L., Ruggeri, E. M., Sperduti, I., Vaccaro, V.   +9 more
core   +1 more source

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study

BMC Cancer, 2023
Background This study aimed to investigate the association between baseline serum tumor markers (STMs) (carcinoembryonic antigen [CEA], neuron-specific enolase [NSE], cytokeratin-19 fragment [CYFRA21-1], carbohydrate antigen 19–9 [CA19-9], and ...
Jian Huang, Yi Xiao, Yubin Zhou, Huiyin Deng, Zihao Yuan, Longyan Dong, Jun Lan, Xiane Li, Gaijiao Liu, Hao Hu, Shaohong Huang, Xiongwen Yang   +11 more
doaj   +1 more source

Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore. [PDF]

, 2014
The aim of this study is to determine the efficacy of neoadjuvant chemotherapy (NAC) with gemcitabine (GEM) in combination with fluorescence-guided surgery (FGS) on a pancreatic cancer patient derived orthotopic xenograft (PDOX) model.
Bouvet, Michael, Chishima, Takashi, Endo, Itaru, Fleming, Jason B, Hiroshima, Yukihiko, Hoffman, Robert M, Ichikawa, Yasushi, Katz, Matthew HG, Maawy, Ali, Matsuyama, Ryusei, Momiyama, Masashi, Mori, Ryutaro, Murakami, Takashi, Tanaka, Kuniya, Zhang, Yong   +14 more
core   +3 more sources

The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer

Open Medicine, 2023
This study aimed to explore the value of color Doppler ultrasonography combined with carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) in differential diagnosis of gastric stromal tumor (GST) and gastric cancer (GC).
Cheng Xinyu, Xia Jianguo, Xu Qi, Gui Huawei   +3 more
doaj   +1 more source

Correlation between serum carbohydrate antigen 19-9 levels and computed tomography severity score in patients with nontuberculous mycobacterial pulmonary disease

Scientific Reports, 2021
There is no validated clinical biomarker for disease severity or treatment response for nontuberculous mycobacterial pulmonary disease (NTM-PD). We investigated the correlation between elevated serum carbohydrate antigen (CA) 19-9 levels and NTM-PD ...
Kangjoon Kim, Seung Hyun Yong, Su Hwan Lee, Sang Hoon Lee, Ah Young Leem, Song Yee Kim, Kyungsoo Chung, Eun Young Kim, Ji Ye Jung, Moo Suk Park, Young Sam Kim, Hye-Jeong Lee, Young Ae Kang   +12 more
doaj   +1 more source

Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials. [PDF]

, 2013
PurposePatients with advanced cholangiocarcinoma (CC) and gallbladder carcinoma (GC) have few therapeutic options for relapsed disease. methods: Given the overall poor prognosis in this population and the availability of novel targeted therapies, we ...
Falchook, Gerald S, Fu, Siqing, Hess, Kenneth R, Hong, David S, Janku, Filip, Javle, Milind, Kaseb, Ahmed O, Kurzrock, Razelle, Naing, Aung, Piha-Paul, Sarina, Subbiah, Ishwaria M, Subbiah, Vivek, Tsimberidou, Apostolia M, Wheler, Jennifer J, Wolff, Robert A   +14 more
core   +2 more sources

Tumor marker elevations in chronic kidney disease: a retrospective study [PDF]

PeerJ
Aim To investigate the changes in tumor markers such as carbohydrate antigen 125 (CA125), carbohydrate antigen 153 (CA15-3), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 72-4 (CA72-4), pro-gastrin-releasing peptide (proGRP), and human ...
Liuxia You, Zhongying Xu, Qiaoling Liu, Guoming Jin, Changting Wang   +4 more
doaj   +2 more sources

Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis. [PDF]

, 2018
BackgroundContinuous-infusion 5-fluorouracil (5FU) and calcium leucovorin plus nab-paclitaxel and oxaliplatin have been shown to be active in patients with pancreatic cancer.
Bedford, Rudolph, Donahue, Timothy, Hines, O Joe, Hoos, William, Isacoff, William H, Rahib, Lola, Reber, Howard A, Upfill-Brown, Alexander   +7 more
core   +1 more source

REPORT OF A PATIENT WITH A HUGE LIVER CYST WHO HAD A HIGH SERUM LEVEL OF CARBOHYDRATE ANTIGEN 19-9 (CA19-9)

The journal of the Japanese Practical Surgeon Society, 1987
The patient was a 65-year-old woman who was admitted with an abdominal mass. CT-scans showed a huge liver cyst that was homogeneous except for one part of the wall which was calfified. Ultrasonograms showed an irregular floating structure in the cyst. Inferior vena cava (IVC) angiograms showed that the IVC was compressed by the cyst and that collateral
Hiromu TANAKA, Katsuji SAKAI, Hiroaki KINOSHITA, Kazuhiro HIROHASHI, Yasutoshi TSUJI, Syoji KOBO, Noritaka TEI, Ryutaro IWASA, Mitsuharu LEE, Koji NAKATA   +9 more
openaire   +2 more sources

Two Cases of the Same Family with the Unusual Elevation of CA19-9 Levels

Acta Médica Portuguesa, 2014
Introduction: Serum carbohydrate associated antigen (CA19-9) is widely used marker in clinical practice and shows small increases in a few benign diseases.
Metin Uyanik, Erdim Sertoglu, Muhittin A. Serdar, Fevzi N. Aydin, Taner Ozgurtas, Ismail Kurt   +5 more
doaj   +1 more source